THERIVA BIOLOGICS INC COM NEW - Stock (SYN)

CUSIP: 87164U201

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Stock
Total 13F shares
7,230,467
Share change
+719,617
Total reported value
$3,322,000
Price per share
$0.46
Number of holders
28
Value change
+$329,940
Number of buys
13
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 87164U201?
CUSIP 87164U201 identifies SYN - THERIVA BIOLOGICS INC COM NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERIVA BIOLOGICS INC COM NEW - Stock (SYN) as of Q3 2021

As of 30 Sep 2021, THERIVA BIOLOGICS INC COM NEW - Stock (SYN) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,230,467 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, GSA CAPITAL PARTNERS LLP, NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, BLAIR WILLIAM & CO/IL, Virtu Financial LLC, and TWO SIGMA ADVISERS, LP. This page lists 28 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.